Phase 4
N=26
Impact of Astaxanthin on Cognition in Recreationally Active Females
Mental Fatigue
Bottom Line
View on ClinicalTrials.gov: NCT06460181 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
May 2026
Primary outcome: Primary: Reaction Time — 402.7; 400; 426.4; 406.6 milliseconds
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Astaxanthin (Dietary_supplement); Placebo (Dietary_supplement)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of North Alabama
- Primary completion
- Nov 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Reaction Time |
402.7; 400; 426.4; 406.6; 937.2; 948.0 | — |
Summary
The purpose of this study is to examine the protentional that the antioxidant Astaxanthin has on mitigating cognitive decline following mental fatigue.
Eligibility Criteria
Inclusion Criteria
- The participant population will be healthy, recreationally active females between the ages of 18-39 without any medical conditions. To be deemed recreationally active, they must meet the World Health Organization minimum activity guidelines of completing at least 150 to 300 min moderate-intensity activity or 75-150 min of vigorous-intensity activity a week, plus muscle-strengthening activities 2 or more days a week.
- Adult females with a stable body weight (± 5 lbs.) for 2 months
- Adult females with a normal menstrual cycle
- Adult females not on a low-carb, high-fat diet or intermittent fasting
- Adult females who are not pregnant of actively attempting to become pregnant
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT06460181). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.